Study Stopped
Study never started - halted by funder
A Trial of Mindfulness Meditation for Chronic Insomnia
MMI
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
To evaluate the efficacy of mediation therapies on measures of sleep and arousal for people with chronic insomnia and with this the viability of smartphone delivered meditation based approaches at a population level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2018
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2017
CompletedFirst Posted
Study publicly available on registry
November 8, 2017
CompletedStudy Start
First participant enrolled
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedFebruary 18, 2020
February 1, 2020
3 months
October 27, 2017
February 14, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Insomnia Severity (Insomnia Severity Index)
Insomnia Severity Index (ISI): The Insomnia Severity Index has seven questions. The seven answers are added up to get a total score. This will be administered at baseline, after 8-weeks and at a 3 and 6-month follow-up. The index will be sent to by post and. It will take approximately 5 minutes to complete.
8 weeks, 3 and 6 month follow-up
Change in Actigraphy determined wake time (TWT)
Actigraphy: Sleep onset latency (SOL) and wake after sleep onset (WASO) will be determined using wrist actigraphy. Participants will be provided with an actiwatch during the screening interview conducted at the beginning of the study. The actiwatch will be worn on the non-dominant arm 24 hours a day, except for while bathing, during the 2-week screening period. Additionally, the actiwatch will be worn for one week after the 8-week intervention and for one week prior to the 3 and 6-month follow-up. Participants will send the actiwatch to the investigator by post after each measurement period. The actiwatch will be sent to participants by post before the next measurement point; apart from the first time point where the participant will be given the actiwatch.
2-week screening, 8-week intervention, 3 and 6-month follow-up
Secondary Outcomes (2)
Review of mobile-based mindfulness meditation application for insomnia
6 months
Mindfulness (CAMS-R)
Baseline, 8-weeks, 3 and 6-month follow-up
Study Arms (2)
Experimental (Mindfulness)
EXPERIMENTALThis arm will receive mindfulness-based interventions through a mobile application
Control (Sleep Advice)
NO INTERVENTIONThis is the control arm that will receive usual care
Interventions
Mindfulness Meditation delivered through a mobile application
Eligibility Criteria
You may qualify if:
- Over the age of 18
- Meet the diagnostic criteria for an insomnia disorder. Defined as difficulty initiating or maintaining sleep despite adequate opportunity, with at least one symptom of an associated daytime impairment. Additional quantitative insomnia criteria following research recommendations include frequency (defined as sleep onset latency (SOL) or wake after sleep onset (WASO) \> 30 minutes at least 3 nights per week and for chronicity, defined as symptoms lasting \> 6 months.
- Have access to an iOS or Android smartphone or a desktop computer with Internet access
- Participants will be required to sign an informed consent form
You may not qualify if:
- Uncontrolled medical condition suspected to interfere with sleep or requiring immediate treatment outside of the study
- Uncontrolled psychiatric conditions requiring immediate treatment outside of the study, including current major depressive episode
- Comorbid sleep disorders including obstructive sleep apnea
- Current use of hypnotic or sedating medications for the purpose of insomnia
- Inadequate proficiency in English to complete the protocol
- Participation in other trials concurrently
- Regular meditation practice defined as equal to or more than 2x weekly for the past 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nicholas Hart, MD
Guys and St Thomas NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2017
First Posted
November 8, 2017
Study Start
May 1, 2018
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
February 18, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share